Research report on global market for cell-based assays

BioInformatics LLC has announced the release of their latest report, The Market for Cell-Based Assays.

Cell-based assays are a critical component in the laboratories of researchers performing drug discovery and screening, studying cellular function, researching disease mechanisms and many other applications. Because of their position in the spectrum of research model systems, these assays have become an essential tool for researchers in both academic and pharmaceutical markets.

Leading suppliers in this market include companies making a wide variety of instruments and consumables, including Thermo Fisher Scientific, Promega and Bio-Rad Laboratories, but also many smaller suppliers of specific assays or instrument platforms such as Seahorse Biosciences and BMG Labtech. This highly fragmented market presents an opportunity for smaller manufacturers to offer highly specialized assays that meet a particular market need, while larger suppliers will continue to leverage their scale and channel access to make a wide variety of products available to researchers.

Key findings from the report:

• Global market for cell-based assays in 2015 is estimated to be $3.9B
• 19% of respondents say they are highly likely to switch primary suppliers of cell-based assay products in the next 12 months
• 29% of respondents expect weekly throughput to increase in 2015

The Market for Cell-Based Assays is the second in a series of topics to be explored using the Interactive Market Intelligence platform. The primary research analysis is based on a survey of 800+ international scientists using cell-based assays in their laboratories.